SITC Workshop Presentations

October 24-25, 2012
8:00 am - 5:00 pm
Bethesda North Marriott Hotel & Conference Center
North Bethesda, MD

Presentations are posted online based upon presenter approval.

Program Schedule

Wednesday, October 24
7:00 am - 8:00 am Registration and Continental Breakfast Session 100: Keynote Address
8:00 am - 9:00 am	Immunity in Cancer Growth and Progression Nicholas P. Restifo, MD - National Cancer Institute
Session 101: Cells of the Immune System In the Tumor Microenvironment
9:00 am - 9:30 am	Integrative Cancer Immunology: Importance of T Cells Jerome Galon, PhD - INSERM- Cordeliers Research Center
9:30 am - 10:00 am	T Lymphocytes in Human Melanoma Metastases Pierre G. Coulie, MD, PhD - De Duve Institute and University of Louvain
10:00 am - 10:30 am	Refreshments and Networking
Session 102: Stromal Elements of the Tumor Microenvironment
10:30 am - 11:00 am	Endothelial Regulation of T cell Trafficking in Tumors George Coukos, MD, PhD - University of Pennsylvania Medical Center
11:00 am - 11:30 am	Immune Suppression by Stromal Cells David H. Munn, MD - Georgia Health Sciences University
11:30 am - 12:00 pm	Relapse of Cancer: Stromal Cross-Presentation is Required for the Elimination of Escape Variants Hans Schreiber, MD, PhD - University of Chicago
12:00 pm - 1:30 pm	Lunch Break and Networking
Session 103: Inflammation and Immune Trafficking
1:30 pm - 2:00 pm	Innate and Adaptive Immunity Regulated Within the Tumor Microenvironment Thomas F. Gajewski, MD, PhD - University of Chicago
2:00 pm - 2:30 pm	Chemotherapy Alters a Tolerogenic Environment in the Spleen of Tumor- Bearing Hosts Vincenzo Bronte, MD - University of Verona
2:30 pm - 3:00 pm	An Experimentally Verified Quantitative Model and In Vitro Methods that Enable Cellular Immunotherapists to Calculate the Concentration of Cytolytically Active Immune Effector Cells Required to Produce Sterilizing Immunity in Neoplastic and Infectious Diseases Samuel C. Silverstein, MD - Columbia University
3:00 pm - 3:30 pm	Manipulating MDSC to Promote Regression Dmitry I. Gabrilovich, MD, PhD - H. Lee Moffitt Cancer Center and Research Institute
Session 104: Keynote Address
3:30 pm - 4:30 pm	Mechanisms of Protective Tumor Immunity Glenn Dranoff, MD - Dana-Farber Cancer Institute
Thursday, October 25
7:00 am - 8:00 am Registration and Continental Breakfast
Session 200: Remodeling the Tumor Microenvironment to Promote Tumor Regression
8:00 am - 8:30 am	Oncogene Inactivation and CD4+ T Cells Dean W. Felsher, MD, PhD - Stanford University School of Medicine
8:30 am - 9:00 am	Immune Checkpoint Modulation and the Tumor Microenvironment Drew M. Pardoll, MD, PhD - Johns Hopkins University School of Medicine
9:00 am - 9:30 am	Immune Impact on Cancer Stemness and Metastasis Weiping Zou, MD, PhD - University of Michigan
9:30 am - 10:00 am	Manipulating T Cells to Promote Regression Laurence J.N. Cooper, MD, PhD - MD Anderson Cancer Center
10:00 am - 10:30 am	Refreshments and Networking
Session 201: Monitoring Immune Responses with the Tumor Microenvironment
10:30 am - 11:00 am	Microenvironment Immunogenetics Biomarkers in Combination Immunotherapy Samir N. Khleif, MD - Georgia Health Sciences University
11:00 am - 11:30 am	Visualizing CTL and NK Cells Cytotoxic Activity in Solid Tumors Philippe Bousso, PhD - INSERM U668
11:30 am - 12:00 pm	Epigenetic Immune Cell Markers - Enabling Novel Clinical Trials with Robust Results from Frozen Whole Blood or Tissue Thomas O. Kleen, PhD - Epiontis GmbH
12:00 pm - 12:30 pm	Immune Response Signatures and Patient Survival Mary L. Disis, MD - University of Washington
12:30 pm - 2:00 pm	Lunch Break and Networking
Session 202: Clinical Trials: Provoking Immunity in the Tumor Microenvironment
2:00 pm - 2:30 pm	Combination Immunotherapies Designed to Target the Tumor Microenvironment Leisha A. Emens, MD, PhD - Johns Hopkins University
2:30 pm - 2:50  pm	MDSC Inhibition Augments Immune Function in Head and Neck Cancer Patients: Results of PDE5 Inhibition Ivan Borrello, MD - Johns Hopkins University School of Medicine
2:50 pm - 3:10 pm	Clinical Trials: Provoking Immunity in the Tumor Microenvironment Antoni Ribas, MD - UCLA Medical Center
3:10 pm - 3:30 pm	Sunitinib and Immunity Brian I. Rini, MD - Cleveland Clinic Taussig Cancer Center
Session 203: Immunoscore
3:30 pm - 3:50 pm	The Immunoscore: A Proposal for a New Classification of Cancer in the Era of Immunotherapies Jerome Galon, PhD - INSERM- Cordeliers Research Center
3:50 pm - 4:10 pm	The Impact of Immune Cell Infiltration on Patient Prognosis Alessandro Lugli, MD - Institut of Pathology University of Bern
4:10 pm - 4:30 pm	A Strategic View of the Immunoscore Bernard A. Fox, PhD - Earle A. Chiles Research Institute
4:30 pm - 4:50 pm	Immune System and Cancer: Importance of the Immunoscore Francesco Marincola, MD - National Institutes of Health
4:50 pm - 5:00 pm	Closing Comment

All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.